The 'go to' European specialist pharma company
[i] Blachier M, Leleu H, Peck-Radosavljevic et al. The burden of liver disease in Europe. A review of available epidemiological data. EASL, 2013
[iii] Orr J.G. et al. Resource use associated with hepatic encephalopathy in patients with liver disease. International Liver Congress 2014, Abstract P478
Norgine’s Phase III product NER1006 enrols first patients into MORA and DAYB EU studies http://t.co/cazvV5Aqss
Check out our poster PCN97 being presented at #ISPOR on the impact of bowel cleansing on prevention of colorectal cancer
P.Martin, Chief Operating Officer: "Construction of the new warehouse demonstrates our investment in the Hengoed site"
@Norgine invests in multi-million pound warehouse in Hengoed, Wales